532523:BOM
Biocon Ltd
₹ ३५०.००
arrow_downward
-०.४३%(-१.५०) 1D
अक्टोबर १६, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532523...
Open
₹ ३५२.९५
High
₹ ३५२.९५
Low
₹ ३४८.१०
Mkt. cap
५.६९ खरब
Avg. vol.
६.९३ लाख
Volume
६.६८ लाख
Dividend
०.१४%
Quarterly dividend
₹ ०.१३
Ex-dividend date
२०२६ जुलाई ३
P/E ratio
१०३.६२
52-wk high
₹ ४४७.००
52-wk low
₹ ३३७.९५
EPS
₹ ३.३८
Shares outstanding
६०.०० करोड
No. of employees
१६ हजार
Open
₹ ३५२.९५
High
₹ ३५२.९५
Low
₹ ३४८.१०
Mkt. cap
५.६९ खरब
Avg. vol.
६.९३ लाख
Volume
६.६८ लाख
Dividend
०.१४%
Quarterly dividend
₹ ०.१३
Ex-dividend date
२०२६ जुलाई ३
P/E ratio
१०३.६२
52-wk high
₹ ४४७.००
52-wk low
₹ ३३७.९५
EPS
₹ ३.३८
Shares outstanding
६०.०० करोड
No. of employees
१६ हजार
News stories
From web sources and news partners
Yahoo Finance
·
२९ मिनेट पहिले
Howard Marks: The S&P 500 isn’t a good bet right now
The Motley Fool
·
६ मिनेट पहिले
Prediction: Oracle Stock Trails the S&P 500 Through 2030
조선일보
·
६ मिनेट पहिले
SK Hynix Faces Backlash Over Solidigm's $100B Nasdaq Listing
MarketWatch
·
१ दिन पहिले
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees१६.४ हजार
Founded१९७८ नोभेम्बर २९
Headquartersबेङ्गलोर, कर्नाटक, भारत
Sector-
Websitebiocon.com